San Francisco, CA, United States of America

Mickey S Urdea


Average Co-Inventor Count = 2.3

ph-index = 9

Forward Citations = 658(Granted Patents)


Location History:

  • Alamo, CA (US) (1989)
  • San Francisco, CA (US) (1984 - 1997)

Company Filing History:


Years Active: 1984-1997

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mickey S Urdea

Introduction

Mickey S Urdea is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in vaccine development and recombinant DNA technology. With a total of 9 patents to his name, Urdea's work has had a lasting impact on medical science.

Latest Patents

One of Urdea's latest patents is for a recombinant herpes simplex gD vaccine. This vaccine contains recombinant polypeptides that are cross-reactive with glycoprotein D of the herpes simplex virus. The patent outlines methods for producing the vaccine using recombinant DNA techniques in yeast, as well as methods for its application. Additionally, E. coli strains HB101 containing plasmids pYHS 109 and pYHS118 were deposited at the American Type Culture Collection on July 11, 1984, and were granted accession numbers 39762 and 39763, respectively. Another significant patent involves the gene for human epidermal growth factor, which has been synthesized in blocks and cloned. Novel recombinant DNA transfer vectors containing this cloned DNA have been constructed, reflecting the codon bias of yeast. This DNA sequence is crucial for the large-scale synthesis of human epidermal growth factor in yeast cells or microorganisms transformed by the recombinant DNA transfer vectors.

Career Highlights

Mickey S Urdea has had a distinguished career, primarily working with Chiron Corporation. His innovative work in vaccine development and recombinant DNA technology has positioned him as a leader in the biotechnology sector. His contributions have not only advanced scientific understanding but have also paved the way for new therapeutic approaches.

Collaborations

Throughout his career, Urdea has collaborated with notable colleagues, including Pablo D Valenzuela and Brian David Warner. These partnerships have fostered a collaborative environment that has led to groundbreaking advancements in their respective fields.

Conclusion

Mickey S Urdea's contributions to biotechnology and vaccine development are noteworthy. His innovative patents and collaborations have significantly advanced the field, making him a key figure in medical science. His work continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…